Stay updated on JAK1 Inhibitor With Topical Therapy Clinical Trial
Sign up to get notified when there's something new on the JAK1 Inhibitor With Topical Therapy Clinical Trial page.

Latest updates to the JAK1 Inhibitor With Topical Therapy Clinical Trial page
- CheckyesterdayChange DetectedPage version updated to v3.0.2 (from v3.0.1) and the 'Back to Top' link removed; the rest of the content remains unchanged.SummaryDifference0.1%
- Check9 days agoChange DetectedThe page has updated the citation for a study on Abrocitinib in adolescents with atopic dermatitis, reflecting a new version and publication date.SummaryDifference0.2%
- Check16 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new facility names and locations, particularly in Mexico, the United States, and various cities in Europe and Asia. Additionally, new drug information related to Abrocitinib has been included, enhancing the content's relevance and accuracy.SummaryDifference5%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.0%
- Check44 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.4%
Stay in the know with updates to JAK1 Inhibitor With Topical Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JAK1 Inhibitor With Topical Therapy Clinical Trial page.